Carbonnelle, D. | IICIMED

Carbonnelle, D.

Publications

P201

Lipids Health Dis. 2019, 18, 168.

4-cholesten-3-one decreases breast cancer cell viability and alters membrane raft-localized EGFR expression by reducing lipogenesis and enhancing LXR-dependent cholesterol transporters.

Elia, J. | Carbonnelle, D. | Logé, C. | Ory, L. | Huvelin, J.-M. | Tannoury, M. | Diab-Assaf, M. | Petit, K. | Nazih, H.

doi: 10.1186/s12944-019-1103-7

P78

J. Pharmacol. Exp. Ther., 2009, 331(2), 710-716.

A novel indole-3-propanamide exerts its immunosuppressive activity by inhibiting JAK3 in T cells.

Carbonnelle, D. | Duflos, M. | Marchand, P. | Chauvet, C. | Petit, J-Y. | Lang, F.

P56

Eur. J. Med. Chem., 2007, 42(5), 686-693.

Synthetic N-pyridinyl(methyl)-indol-3-ylpropanamides as new potential immunosuppressive agents.

Carbonnelle, D. | Lardic, M. | Dassonville, A. | Verron, E. | Petit, J-Y. | Duflos, M. | Lang, F.

P42

Eur. J. Immunol. 2005, 35, 546-56. 

A new  carboxamide compound exerts immuno-suppressive activity by inhibiting dendritic cell maturation.

Carbonnelle, D. | Ebstein, F. | Rabu, C. | Petit, J-Y. | Grégoire, M. | Lang, F.

P41

J. Enz. Inh. Med. Chem. 2004, 19, 459-465.

Synthesis and evaluation of N3-imidazolidin-2-one acting as potential immunosuppressive agents.

Sabourin, C. | Robert, J-M.H. | Robert-Piessard, S. | Carbonnelle, D. | Lang, F.

Autres publications scientifiques

Brevets

Thèse